Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Defining the importance of stress reduction in managing cardiovascular disease - the role of exercise.
Popovic D, Bjelobrk M, Tesic M, Seman S, Jayasinghe S, Hills AP, Babu AS, Jakovljevic DG, Stoner L, Ozemek C, Bond S, Faghy MA, Pronk NP, Lavie CJ, Arena R; HL - PIVOT Network. Popovic D, et al. Among authors: tesic m. Prog Cardiovasc Dis. 2022 Jan-Feb;70:84-93. doi: 10.1016/j.pcad.2022.01.008. Epub 2022 Feb 4. Prog Cardiovasc Dis. 2022. PMID: 35131232 Review.
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry.
Lund LH, Crespo-Leiro MG, Laroche C, Zaliaduonyte D, Saad AM, Fonseca C, Čelutkienė J, Zdravkovic M, Bielecka-Dabrowa AM, Agostoni P, Xuereb RG, Neronova KV, Lelonek M, Cavusoglu Y, Gellen B, Abdelhamid M, Hammoudi N, Anker SD, Chioncel O, Filippatos G, Lainscak M, McDonagh TA, Mebazaa A, Piepoli M, Ruschitzka F, Seferović PM, Savarese G, Metra M, Rosano GMC, Maggioni AP; ESC EORP HF III National Leaders and Investigators. Lund LH, et al. Eur J Heart Fail. 2024 Dec;26(12):2487-2501. doi: 10.1002/ejhf.3445. Epub 2024 Sep 10. Eur J Heart Fail. 2024. PMID: 39257278 Free PMC article.
Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry.
Boriani G, Proietti M, Laroche C, Fauchier L, Marin F, Nabauer M, Potpara T, Dan GA, Kalarus Z, Diemberger I, Tavazzi L, Maggioni AP, Lip GYH; EORP-AF Long-Term General Registry Investigators; Steering Committee (National Coordinators). Boriani G, et al. Europace. 2018 May 1;20(5):747-757. doi: 10.1093/europace/eux301. Europace. 2018. PMID: 29016832 Free article.
Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.
Velicki L, Jakovljevic DG, Preveden A, Golubovic M, Bjelobrk M, Ilic A, Stojsic S, Barlocco F, Tafelmeier M, Okwose N, Tesic M, Brennan P, Popovic D, Ristic A, MacGowan GA, Filipovic N, Maier LS, Olivotto I. Velicki L, et al. Among authors: tesic m. BMC Cardiovasc Disord. 2020 Dec 9;20(1):516. doi: 10.1186/s12872-020-01807-4. BMC Cardiovasc Disord. 2020. PMID: 33297970 Free PMC article.
The Role of Cardiopulmonary Exercise Testing in Hypertrophic Cardiomyopathy.
Mikic L, Ristic A, Markovic Nikolic N, Tesic M, Jakovljevic DG, Arena R, Allison TG, Popovic D. Mikic L, et al. Among authors: tesic m. Medicina (Kaunas). 2023 Jul 13;59(7):1296. doi: 10.3390/medicina59071296. Medicina (Kaunas). 2023. PMID: 37512108 Free PMC article. Review.
Sacubitril/valsartan for the treatment of non-obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM).
Velicki L, Popovic D, Okwose NC, Preveden A, Tesic M, Tafelmeier M, Charman SJ, Barlocco F, MacGowan GA, Seferovic PM, Filipovic N, Ristic A, Olivotto I, Maier LS, Jakovljevic DG; SILICOFCM Investigators. Velicki L, et al. Among authors: tesic m. Eur J Heart Fail. 2024 Jun;26(6):1361-1368. doi: 10.1002/ejhf.3291. Epub 2024 May 27. Eur J Heart Fail. 2024. PMID: 38800948 Clinical Trial.
The ventilatory efficiency parameters outperform peak oxygen consumption in monitoring the therapy effects in patients with hypertrophic cardiomyopathy.
Seman S, Tesic M, Babic M, Mikic L, Velicki L, Okwose NC, Charman SJ, Tafelmeier M, Olivotto I, Filipovic N, Ristic A, Arena R, Guazzi M, Jakovljevic D, Allison TG, Popovic D; SILICOFCM study investigators. Seman S, et al. Among authors: tesic m. Prog Cardiovasc Dis. 2024 Nov-Dec;87:90-96. doi: 10.1016/j.pcad.2024.10.005. Epub 2024 Oct 16. Prog Cardiovasc Dis. 2024. PMID: 39424165 Clinical Trial.
125 results